Wird geladen...

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant

Ovarian cancer is the most lethal gynecologic malignancy. Surgery and chemotherapy are the primary treatments for ovarian cancer; however, patients often succumb to recurrence with chemotherapeutic resistance within several years after the initial treatment. In the past two decades, immunotherapy ha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Immunol
Hauptverfasser: Yang, Chang, Xia, Bai-Rong, Zhang, Zhao-Cong, Zhang, Yong-Jian, Lou, Ge, Jin, Wei-Lin
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2020
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7572849/
https://ncbi.nlm.nih.gov/pubmed/33123161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.577869
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!